Impact of Comorbidity Burden in Treatment and Outcome of Older Patients with Indolent Non-Hodgkin Lymphomas

被引：0
|
作者：
Gritti, Giuseppe [1 ]
Stefanoni, Paola [2 ]
Boschini, Cristina [2 ]
Rossi, Andrea [2 ]
Barbui, Anna Maria [1 ]
Rambaldi, Alessandro
机构：
[1] Hosp Papa Giovanni XXIII, Dept Hematol, Bergamo, Italy
[2] Azienda Osped Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
    Lori A. Leslie
    Current Treatment Options in Oncology, 2021, 22
  • [22] Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
    Leslie, Lori A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (12)
  • [23] IMMUNODEFICIENCY IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
    JONES, SE
    GRIFFITH, K
    DOMBROWSKI, P
    GAINES, JA
    BLOOD, 1977, 49 (03) : 335 - 344
  • [24] Intronic polymorphisms of antionkogene TP53 in patients with indolent variants of non-Hodgkin lymphomas
    Voropaeva E.N.
    Voevoda M.I.
    Pospelova T.I.
    Maksimov V.N.
    Advances in Gerontology, 2014, 4 (1) : 42 - 45
  • [25] STUDY OF GENE POLYMORPHISMS AS PREDICTORS OF TREATMENT EFFICACY AND TOXICITY IN PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMAS RECEIVING BENDAMUSTINE AND RITUXIMAB
    Cencini, E.
    Sicuranza, A.
    Fabbri, A.
    Raspadori, D.
    Bocchia, M.
    HAEMATOLOGICA, 2017, 102 : 109 - 109
  • [26] STUDY OF GENE POLYMORPHISMS AS PREDICTORS OF TREATMENT EFFICACY AND TOXICITY IN PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMAS RECEIVING BENDAMUSTINE AND RITUXIMAB
    Cencini, E.
    Sicuranza, A.
    Fabbri, A.
    Raspadori, D.
    Bocchia, M.
    HAEMATOLOGICA, 2016, 101 : S85 - S85
  • [27] FACTORS IMPACTING TREATMENT DECISION MAKING IN OLDER ADULTS WITH INDOLENT NON-HODGKIN LYMPHOMA
    Trevino, Kelly
    Martin, Peter
    Leonard, John
    INNOVATION IN AGING, 2021, 5 : 513 - 513
  • [28] IDELALISIB FOR THE TREATMENT OF INDOLENT NON-HODGKIN'S LYMPHOMA
    Lopez, J. P.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (02) : 113 - 120
  • [29] Current data from the ASH on Bendamustin in indolent non-Hodgkin lymphomas and satellite cell lymphomas
    不详
    ONKOLOGIE, 2006, 29 (03): : 116 - 116
  • [30] NON-HODGKIN LYMPHOMAS
    WEIL, M
    JACQUILLAT, C
    DUMONT, J
    NOUVELLE PRESSE MEDICALE, 1981, 10 (27): : 2255 - 2256
12345